NCT04681131 2025-09-25CAB-AXL-ADC Safety and Efficacy Study in Adults With NSCLCBioAtla, Inc.Phase 2 Completed85 enrolled
NCT05704985 2025-05-29Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ TumorsDEKA BiosciencesPhase 1 Active not recruiting39 enrolled